MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2

Mutations in mitofusin 2 (MFN2) have been reported in Charcot-Marie-Tooth type 2 (CMT2) families. To study the distribution of mutations in MFN2 we screened 323 families and isolated patients with distinct CMT phenotypes. In 29 probands, we identified 22 distinct MFN2 mutations, and 14 of these muta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain 2006-08, Vol.129 (8), p.2093-2102
Hauptverfasser: Verhoeven, Kristien, Claeys, Kristl, Züchner, S, Schröder, M.J, Weis, J, Ceuterick, C, Jordanova, A, Nelis, E, De Vriendt, E, Van Hul, M, Seeman, P, Mazanec, R, Saifi, G.M, Szigeti, K, Mancias, P, Butler, I.J, Kochanski, A, Ryniewicz, B, de Bleecker, J, Van den Berg, P, Verellen, C, Van Coster, R, Goemans, N, Auer-Grumbach, M, Robberecht, W, Rasic, V.M, Nevo, Y, Tournev, I, Guergueltcheva, V, Roelens, F, Vieregge, P, Vinci, P, Moreno, M.T, Christen, H.-J, Shy, M.E, Lupski, J.R, Vance, J.M, De Jonghe, P, Timmerman, V
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2102
container_issue 8
container_start_page 2093
container_title Brain
container_volume 129
creator Verhoeven, Kristien
Claeys, Kristl
Züchner, S
Schröder, M.J
Weis, J
Ceuterick, C
Jordanova, A
Nelis, E
De Vriendt, E
Van Hul, M
Seeman, P
Mazanec, R
Saifi, G.M
Szigeti, K
Mancias, P
Butler, I.J
Kochanski, A
Ryniewicz, B
de Bleecker, J
Van den Berg, P
Verellen, C
Van Coster, R
Goemans, N
Auer-Grumbach, M
Robberecht, W
Rasic, V.M
Nevo, Y
Tournev, I
Guergueltcheva, V
Roelens, F
Vieregge, P
Vinci, P
Moreno, M.T
Christen, H.-J
Shy, M.E
Lupski, J.R
Vance, J.M
De Jonghe, P
Timmerman, V
description Mutations in mitofusin 2 (MFN2) have been reported in Charcot-Marie-Tooth type 2 (CMT2) families. To study the distribution of mutations in MFN2 we screened 323 families and isolated patients with distinct CMT phenotypes. In 29 probands, we identified 22 distinct MFN2 mutations, and 14 of these mutations have not been reported before. All mutations were located in the cytoplasmic domains of the MFN2 protein. Patients presented with a classical but rather severe CMT phenotype, since 28% of them were wheelchair-dependent. Some had additional features as optic atrophy. Most patients had an early onset and severe disease status, whereas a smaller group experienced a later onset and milder disease course. Electrophysiological data showed in the majority of patients normal to slightly reduced nerve conduction velocities with often severely reduced amplitudes of the compound motor and sensory nerve action potentials. Examination of sural nerve specimens showed loss of large myelinated fibres and degenerative mitochondrial changes. In patients with a documented family history of CMT2 the frequency of MFN2 mutations was 33% indicating that MFN2 mutations are a major cause in this population.
format Article
fullrecord <record><control><sourceid>kuleuven</sourceid><recordid>TN_cdi_kuleuven_dspace_123456789_342631</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>123456789_342631</sourcerecordid><originalsourceid>FETCH-kuleuven_dspace_123456789_3426313</originalsourceid><addsrcrecordid>eNqNzL0OgjAABOAOmog_79DNwTSWFirMROKCE5tDU6FKFVvSFqNvb4I8ANPdJV9uBgKMMUNJGuMFWDr3wDiMKGEBuBT5mcBX74VXRsNaOW_VtR-G0DW8S238t5P7rhkbrIy1sv17pWHWCFsZjwphlUSlMb6BgyNrML-J1snNmCuwzY9ldkLPvpX9W2peu05UkoeERjE7JCmnEWE0pCuwmya5_3g6_fcHalFRBQ</addsrcrecordid><sourcetype>Institutional Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Lirias (KU Leuven Association)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Verhoeven, Kristien ; Claeys, Kristl ; Züchner, S ; Schröder, M.J ; Weis, J ; Ceuterick, C ; Jordanova, A ; Nelis, E ; De Vriendt, E ; Van Hul, M ; Seeman, P ; Mazanec, R ; Saifi, G.M ; Szigeti, K ; Mancias, P ; Butler, I.J ; Kochanski, A ; Ryniewicz, B ; de Bleecker, J ; Van den Berg, P ; Verellen, C ; Van Coster, R ; Goemans, N ; Auer-Grumbach, M ; Robberecht, W ; Rasic, V.M ; Nevo, Y ; Tournev, I ; Guergueltcheva, V ; Roelens, F ; Vieregge, P ; Vinci, P ; Moreno, M.T ; Christen, H.-J ; Shy, M.E ; Lupski, J.R ; Vance, J.M ; De Jonghe, P ; Timmerman, V</creator><creatorcontrib>Verhoeven, Kristien ; Claeys, Kristl ; Züchner, S ; Schröder, M.J ; Weis, J ; Ceuterick, C ; Jordanova, A ; Nelis, E ; De Vriendt, E ; Van Hul, M ; Seeman, P ; Mazanec, R ; Saifi, G.M ; Szigeti, K ; Mancias, P ; Butler, I.J ; Kochanski, A ; Ryniewicz, B ; de Bleecker, J ; Van den Berg, P ; Verellen, C ; Van Coster, R ; Goemans, N ; Auer-Grumbach, M ; Robberecht, W ; Rasic, V.M ; Nevo, Y ; Tournev, I ; Guergueltcheva, V ; Roelens, F ; Vieregge, P ; Vinci, P ; Moreno, M.T ; Christen, H.-J ; Shy, M.E ; Lupski, J.R ; Vance, J.M ; De Jonghe, P ; Timmerman, V</creatorcontrib><description>Mutations in mitofusin 2 (MFN2) have been reported in Charcot-Marie-Tooth type 2 (CMT2) families. To study the distribution of mutations in MFN2 we screened 323 families and isolated patients with distinct CMT phenotypes. In 29 probands, we identified 22 distinct MFN2 mutations, and 14 of these mutations have not been reported before. All mutations were located in the cytoplasmic domains of the MFN2 protein. Patients presented with a classical but rather severe CMT phenotype, since 28% of them were wheelchair-dependent. Some had additional features as optic atrophy. Most patients had an early onset and severe disease status, whereas a smaller group experienced a later onset and milder disease course. Electrophysiological data showed in the majority of patients normal to slightly reduced nerve conduction velocities with often severely reduced amplitudes of the compound motor and sensory nerve action potentials. Examination of sural nerve specimens showed loss of large myelinated fibres and degenerative mitochondrial changes. In patients with a documented family history of CMT2 the frequency of MFN2 mutations was 33% indicating that MFN2 mutations are a major cause in this population.</description><identifier>ISSN: 0006-8950</identifier><language>eng</language><publisher>GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND: Macmillan</publisher><ispartof>Brain, 2006-08, Vol.129 (8), p.2093-2102</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,315,776,780,27837</link.rule.ids></links><search><creatorcontrib>Verhoeven, Kristien</creatorcontrib><creatorcontrib>Claeys, Kristl</creatorcontrib><creatorcontrib>Züchner, S</creatorcontrib><creatorcontrib>Schröder, M.J</creatorcontrib><creatorcontrib>Weis, J</creatorcontrib><creatorcontrib>Ceuterick, C</creatorcontrib><creatorcontrib>Jordanova, A</creatorcontrib><creatorcontrib>Nelis, E</creatorcontrib><creatorcontrib>De Vriendt, E</creatorcontrib><creatorcontrib>Van Hul, M</creatorcontrib><creatorcontrib>Seeman, P</creatorcontrib><creatorcontrib>Mazanec, R</creatorcontrib><creatorcontrib>Saifi, G.M</creatorcontrib><creatorcontrib>Szigeti, K</creatorcontrib><creatorcontrib>Mancias, P</creatorcontrib><creatorcontrib>Butler, I.J</creatorcontrib><creatorcontrib>Kochanski, A</creatorcontrib><creatorcontrib>Ryniewicz, B</creatorcontrib><creatorcontrib>de Bleecker, J</creatorcontrib><creatorcontrib>Van den Berg, P</creatorcontrib><creatorcontrib>Verellen, C</creatorcontrib><creatorcontrib>Van Coster, R</creatorcontrib><creatorcontrib>Goemans, N</creatorcontrib><creatorcontrib>Auer-Grumbach, M</creatorcontrib><creatorcontrib>Robberecht, W</creatorcontrib><creatorcontrib>Rasic, V.M</creatorcontrib><creatorcontrib>Nevo, Y</creatorcontrib><creatorcontrib>Tournev, I</creatorcontrib><creatorcontrib>Guergueltcheva, V</creatorcontrib><creatorcontrib>Roelens, F</creatorcontrib><creatorcontrib>Vieregge, P</creatorcontrib><creatorcontrib>Vinci, P</creatorcontrib><creatorcontrib>Moreno, M.T</creatorcontrib><creatorcontrib>Christen, H.-J</creatorcontrib><creatorcontrib>Shy, M.E</creatorcontrib><creatorcontrib>Lupski, J.R</creatorcontrib><creatorcontrib>Vance, J.M</creatorcontrib><creatorcontrib>De Jonghe, P</creatorcontrib><creatorcontrib>Timmerman, V</creatorcontrib><title>MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2</title><title>Brain</title><description>Mutations in mitofusin 2 (MFN2) have been reported in Charcot-Marie-Tooth type 2 (CMT2) families. To study the distribution of mutations in MFN2 we screened 323 families and isolated patients with distinct CMT phenotypes. In 29 probands, we identified 22 distinct MFN2 mutations, and 14 of these mutations have not been reported before. All mutations were located in the cytoplasmic domains of the MFN2 protein. Patients presented with a classical but rather severe CMT phenotype, since 28% of them were wheelchair-dependent. Some had additional features as optic atrophy. Most patients had an early onset and severe disease status, whereas a smaller group experienced a later onset and milder disease course. Electrophysiological data showed in the majority of patients normal to slightly reduced nerve conduction velocities with often severely reduced amplitudes of the compound motor and sensory nerve action potentials. Examination of sural nerve specimens showed loss of large myelinated fibres and degenerative mitochondrial changes. In patients with a documented family history of CMT2 the frequency of MFN2 mutations was 33% indicating that MFN2 mutations are a major cause in this population.</description><issn>0006-8950</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>FZOIL</sourceid><recordid>eNqNzL0OgjAABOAOmog_79DNwTSWFirMROKCE5tDU6FKFVvSFqNvb4I8ANPdJV9uBgKMMUNJGuMFWDr3wDiMKGEBuBT5mcBX74VXRsNaOW_VtR-G0DW8S238t5P7rhkbrIy1sv17pWHWCFsZjwphlUSlMb6BgyNrML-J1snNmCuwzY9ldkLPvpX9W2peu05UkoeERjE7JCmnEWE0pCuwmya5_3g6_fcHalFRBQ</recordid><startdate>200608</startdate><enddate>200608</enddate><creator>Verhoeven, Kristien</creator><creator>Claeys, Kristl</creator><creator>Züchner, S</creator><creator>Schröder, M.J</creator><creator>Weis, J</creator><creator>Ceuterick, C</creator><creator>Jordanova, A</creator><creator>Nelis, E</creator><creator>De Vriendt, E</creator><creator>Van Hul, M</creator><creator>Seeman, P</creator><creator>Mazanec, R</creator><creator>Saifi, G.M</creator><creator>Szigeti, K</creator><creator>Mancias, P</creator><creator>Butler, I.J</creator><creator>Kochanski, A</creator><creator>Ryniewicz, B</creator><creator>de Bleecker, J</creator><creator>Van den Berg, P</creator><creator>Verellen, C</creator><creator>Van Coster, R</creator><creator>Goemans, N</creator><creator>Auer-Grumbach, M</creator><creator>Robberecht, W</creator><creator>Rasic, V.M</creator><creator>Nevo, Y</creator><creator>Tournev, I</creator><creator>Guergueltcheva, V</creator><creator>Roelens, F</creator><creator>Vieregge, P</creator><creator>Vinci, P</creator><creator>Moreno, M.T</creator><creator>Christen, H.-J</creator><creator>Shy, M.E</creator><creator>Lupski, J.R</creator><creator>Vance, J.M</creator><creator>De Jonghe, P</creator><creator>Timmerman, V</creator><general>Macmillan</general><scope>FZOIL</scope></search><sort><creationdate>200608</creationdate><title>MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2</title><author>Verhoeven, Kristien ; Claeys, Kristl ; Züchner, S ; Schröder, M.J ; Weis, J ; Ceuterick, C ; Jordanova, A ; Nelis, E ; De Vriendt, E ; Van Hul, M ; Seeman, P ; Mazanec, R ; Saifi, G.M ; Szigeti, K ; Mancias, P ; Butler, I.J ; Kochanski, A ; Ryniewicz, B ; de Bleecker, J ; Van den Berg, P ; Verellen, C ; Van Coster, R ; Goemans, N ; Auer-Grumbach, M ; Robberecht, W ; Rasic, V.M ; Nevo, Y ; Tournev, I ; Guergueltcheva, V ; Roelens, F ; Vieregge, P ; Vinci, P ; Moreno, M.T ; Christen, H.-J ; Shy, M.E ; Lupski, J.R ; Vance, J.M ; De Jonghe, P ; Timmerman, V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kuleuven_dspace_123456789_3426313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Verhoeven, Kristien</creatorcontrib><creatorcontrib>Claeys, Kristl</creatorcontrib><creatorcontrib>Züchner, S</creatorcontrib><creatorcontrib>Schröder, M.J</creatorcontrib><creatorcontrib>Weis, J</creatorcontrib><creatorcontrib>Ceuterick, C</creatorcontrib><creatorcontrib>Jordanova, A</creatorcontrib><creatorcontrib>Nelis, E</creatorcontrib><creatorcontrib>De Vriendt, E</creatorcontrib><creatorcontrib>Van Hul, M</creatorcontrib><creatorcontrib>Seeman, P</creatorcontrib><creatorcontrib>Mazanec, R</creatorcontrib><creatorcontrib>Saifi, G.M</creatorcontrib><creatorcontrib>Szigeti, K</creatorcontrib><creatorcontrib>Mancias, P</creatorcontrib><creatorcontrib>Butler, I.J</creatorcontrib><creatorcontrib>Kochanski, A</creatorcontrib><creatorcontrib>Ryniewicz, B</creatorcontrib><creatorcontrib>de Bleecker, J</creatorcontrib><creatorcontrib>Van den Berg, P</creatorcontrib><creatorcontrib>Verellen, C</creatorcontrib><creatorcontrib>Van Coster, R</creatorcontrib><creatorcontrib>Goemans, N</creatorcontrib><creatorcontrib>Auer-Grumbach, M</creatorcontrib><creatorcontrib>Robberecht, W</creatorcontrib><creatorcontrib>Rasic, V.M</creatorcontrib><creatorcontrib>Nevo, Y</creatorcontrib><creatorcontrib>Tournev, I</creatorcontrib><creatorcontrib>Guergueltcheva, V</creatorcontrib><creatorcontrib>Roelens, F</creatorcontrib><creatorcontrib>Vieregge, P</creatorcontrib><creatorcontrib>Vinci, P</creatorcontrib><creatorcontrib>Moreno, M.T</creatorcontrib><creatorcontrib>Christen, H.-J</creatorcontrib><creatorcontrib>Shy, M.E</creatorcontrib><creatorcontrib>Lupski, J.R</creatorcontrib><creatorcontrib>Vance, J.M</creatorcontrib><creatorcontrib>De Jonghe, P</creatorcontrib><creatorcontrib>Timmerman, V</creatorcontrib><collection>Lirias (KU Leuven Association)</collection><jtitle>Brain</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Verhoeven, Kristien</au><au>Claeys, Kristl</au><au>Züchner, S</au><au>Schröder, M.J</au><au>Weis, J</au><au>Ceuterick, C</au><au>Jordanova, A</au><au>Nelis, E</au><au>De Vriendt, E</au><au>Van Hul, M</au><au>Seeman, P</au><au>Mazanec, R</au><au>Saifi, G.M</au><au>Szigeti, K</au><au>Mancias, P</au><au>Butler, I.J</au><au>Kochanski, A</au><au>Ryniewicz, B</au><au>de Bleecker, J</au><au>Van den Berg, P</au><au>Verellen, C</au><au>Van Coster, R</au><au>Goemans, N</au><au>Auer-Grumbach, M</au><au>Robberecht, W</au><au>Rasic, V.M</au><au>Nevo, Y</au><au>Tournev, I</au><au>Guergueltcheva, V</au><au>Roelens, F</au><au>Vieregge, P</au><au>Vinci, P</au><au>Moreno, M.T</au><au>Christen, H.-J</au><au>Shy, M.E</au><au>Lupski, J.R</au><au>Vance, J.M</au><au>De Jonghe, P</au><au>Timmerman, V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2</atitle><jtitle>Brain</jtitle><date>2006-08</date><risdate>2006</risdate><volume>129</volume><issue>8</issue><spage>2093</spage><epage>2102</epage><pages>2093-2102</pages><issn>0006-8950</issn><abstract>Mutations in mitofusin 2 (MFN2) have been reported in Charcot-Marie-Tooth type 2 (CMT2) families. To study the distribution of mutations in MFN2 we screened 323 families and isolated patients with distinct CMT phenotypes. In 29 probands, we identified 22 distinct MFN2 mutations, and 14 of these mutations have not been reported before. All mutations were located in the cytoplasmic domains of the MFN2 protein. Patients presented with a classical but rather severe CMT phenotype, since 28% of them were wheelchair-dependent. Some had additional features as optic atrophy. Most patients had an early onset and severe disease status, whereas a smaller group experienced a later onset and milder disease course. Electrophysiological data showed in the majority of patients normal to slightly reduced nerve conduction velocities with often severely reduced amplitudes of the compound motor and sensory nerve action potentials. Examination of sural nerve specimens showed loss of large myelinated fibres and degenerative mitochondrial changes. In patients with a documented family history of CMT2 the frequency of MFN2 mutations was 33% indicating that MFN2 mutations are a major cause in this population.</abstract><cop>GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND</cop><pub>Macmillan</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-8950
ispartof Brain, 2006-08, Vol.129 (8), p.2093-2102
issn 0006-8950
language eng
recordid cdi_kuleuven_dspace_123456789_342631
source Oxford University Press Journals All Titles (1996-Current); Lirias (KU Leuven Association); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
title MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T21%3A07%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kuleuven&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MFN2%20mutation%20distribution%20and%20genotype/phenotype%20correlation%20in%20Charcot-Marie-Tooth%20type%202&rft.jtitle=Brain&rft.au=Verhoeven,%20Kristien&rft.date=2006-08&rft.volume=129&rft.issue=8&rft.spage=2093&rft.epage=2102&rft.pages=2093-2102&rft.issn=0006-8950&rft_id=info:doi/&rft_dat=%3Ckuleuven%3E123456789_342631%3C/kuleuven%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true